Showing 31-40 of 56 results for "".
- JUVÉDERM VOLUX XC Scores FDA Nod for Jawline Definitionhttps://modernaesthetics.com/news/juvederm-volux-xc-scores-fda-nod-for-jawline-definition/2473275/The U.S. FDA has given its nod to JUVÉDERM VOLUX XC for the improvement of jawline definition in adults over the age of 21 with moderate to severe loss of jawline definition. "The approval of JUVÉDERM VOLUX XC represents the largest leap in innova
- FDA Approves Juvederm Volbella XC for Undereye Hollowshttps://modernaesthetics.com/news/fda-approves-juvederm-volbella-xc-for-undereye-hollows/2473194/FDA has given its nod to Allergan Aesthetics, Juvederm Volbella XC for improvement of infraorbital hollows in adults over the age of 21. Per FDA requirement for this new indication, Allergan Aesthetics is providing a product training program for all interested providers, whic
- Gwyneth Paltrow Named Global Face of Xeominhttps://modernaesthetics.com/news/gwyneth-paltrow-named-global-face-of-xeomin-1/2472991/Actress and Goop wellness guru Gwyneth Paltrow is the first global face of Merz Aesthetic’s Xeomin. In this role, Paltrow will be sharing details about what she does to look and feel her best, and will ask women to do the same on social media using #DareToSelfCare. &ldqu
- FDA Approves Juvéderm Voluma XC for Augmentation for Chin Regionhttps://modernaesthetics.com/news/fda-approves-juvederm-voluma-xc-for-augmentation-for-chin-region/2472953/The FDA has approved Allergan Aesthetics' Juvéderm Voluma XC for the augmentation of the chin region to improve the chin profile in adults over the age of 21. According to Allergan Aesthetics, an AbbVie company, the Juvéderm Collection of Fillers has the broadest portfolio of sp
- FDA Approves Juvéderm Voluma XC For Mid-Face Injection Via Cannulahttps://modernaesthetics.com/news/fda-approves-juvderm-voluma-xc-for-mid-face-injection-via-cannula/2471976/Allergan’s Juvéderm Voluma XC is now U.S. Food and Drug Administration (FDA)-approved for cheek augmentation in the mid-face in adults over 21 with a TSK Steriglide cannula. This cannula features a patented tip design with a near-tip delivery port for precise product p
- xMedica Launches Aesthetics Conference Focused on Energy Based Treatments for Male and Female Sexual Wellnesshttps://modernaesthetics.com/news/xmedica-launches-aesthetics-conference-focused-on-energy-based-treatments-for-male-and-female-sexual-wellness/2472007/Medical education consortium xMedica LLC of Atlanta has developed a new educational initiative, "The Use of Energy-Based Devices for Improving Sexual Health." The overriding goal of this unique conference is to present factual data in a CME setting to address this new are
- Xact Scores Best of Hot Topics at ASAPS 2018https://modernaesthetics.com/news/xact-scores-best-of-hot-topics-at-asaps-2018/2472078/Cypris Medical, Inc.’s Xact technology took home the “Best of Hot Topics” award at the American Society for Aesthetic Plastic Surgery (AS
- Juvéderm Vollure XC FDA Approved for Correction of Facial Wrinkles and Foldshttps://modernaesthetics.com/news/juvderm-vollure-xc-fda-approved-for-correction-of-facial-wrinkles-and-folds/2472255/The FDA has approved Allergan plc's Juvéderm Vollure XC for correction of moderate to severe facial wrinkles and folds, such as nasolabial folds, in adults over the age of 21. In the US pivotal clinical trial, a majority (59 percent) of subjects saw improvement in moderate to severe na
- Happy 20th Birthday Botox Cosmetic!https://modernaesthetics.com/news/happy-20th-birthday-botox-cosmetic/2473218/Allergan Aesthetics’ BOTOX Cosmetic (onabotulinumtoxinA) turns 20 on April 15, 2022. This date marks 20 years since the U.S. Food and Drug Administration (FDA) first approved the product to temporarily improve the look of moderate to severe glabellar lines, located between th
- Candela and VBF Team Up with Physicians to Provide Laser Treatments to Families With Vascular Birthmarkshttps://modernaesthetics.com/news/candela-and-vbf-team-up-with-physicians-to-provide-laser-treatments-to-families-with-vascular-birthmarks/2471984/